Significantly reduced abilities to cross-neutralize SARS-CoV-2 variants by sera from convalescent COVID-19 patients infected by Delta or early strains-Reference-Cited by-同舟云学术

Significantly reduced abilities to cross-neutralize SARS-CoV-2 variants by sera from convalescent COVID-19 patients infected by Delta or early strains

Published:2021-10-11 Issue:11 Volume:18 Page:2560-2562
ISSN:1672-7681
Container-title:Cellular & Molecular Immunology
language:en
Short-container-title:Cell Mol Immunol

Author:

Pan Ting,Hu Zhongwei,Hu Fengyu,Zhang Yiwen^ORCID,Liu Bingfeng,Ke Changwen,She Qiumin,He Xin^ORCID,Tang Xiaoping,Zhang Hui^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Link

https://www.nature.com/articles/s41423-021-00776-8.pdf

Reference10 articles.

1. Robson, F, Khan KS, Le TK, Paris C, Demirbag S, Barfuss P, et al. Coronavirus RNA proofreading: molecular basis and therapeutic targeting. Mol Cell. 2020;80:1136–8. https://doi.org/10.1016/j.molcel.2020.11.048.

2. Wibmer CK, Ayres F, Hermanus T, Madzivhandila M, Kgagudi P, Oosthuysen B, et al. SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. Nat Med. 2021;27:622–5. https://doi.org/10.1038/s41591-021-01285-x.

3. Starr TN, Greaney AJ, Hilton SK, Ellis D, Crawford KHD, Dingens AS, et al. Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding. Cell. 2020;182:1295. https://doi.org/10.1016/j.cell.2020.08.012.

4. Zhou D, Dejnirattisai W, Supasa P, Liu C, Mentzer AJ, Ginn HM, et al. Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera. Cell. 2021;184:2348–61. https://doi.org/10.1016/j.cell.2021.02.037. e2346.

5. Chia PY, Onget SWX, Chiew CJ, Ang LW, Chavatte J-M, Mak T-M, et al. Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study. 2021. https://doi.org/10.1101/2021.07.28.21261295.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 virus-like particle variants alpha and delta mimic the native viruses in their differential inflammasome activating potential;Antiviral Research;2024-04

2. The protection quest is a primary key to sharing the neutralizing antibody response to cover against all emerging VOCs based on BIV1-CovIran studies;Heliyon;2023-03

3. Antibody response and cross-neutralization after Omicron BA.2 infection;Signal Transduction and Targeted Therapy;2023-01-07

4. Immunogenicity and Efficacy of Monovalent and Bivalent Formulations of a Virus-Like Particle Vaccine against SARS-CoV-2;Vaccines;2022-11-24

5. Phenotypic and functional changes of T cell subsets after CoronaVac vaccination;Vaccine;2022-11